eligibility for clinicaltrials:NCT02510001 [clinicaltrials_resource:08ddcc125e7316b0443e4ab13591ff6e]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT02510001 [clinicaltrials_resource:08ddcc125e7316b0443e4ab13591ff6e]
Bio2RDF identifier
08ddcc125e7316b0443e4ab13591ff6e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:08ddcc125e7316b0443e4ab13591ff6e
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
A ...... ibitor and/or a MEK inhibitor.
identifier
clinicaltrials_resource:08ddcc125e7316b0443e4ab13591ff6e
title
eligibility for clinicaltrials:NCT02510001
@en
type
label
eligibility for clinicaltrials ...... dcc125e7316b0443e4ab13591ff6e]
@en